Press Releases
AcouSort receives order for AcouTrap from the University of Kentucky
AcouSort has received an order for an AcouTrap system from the University of Kentucky. The order is a direct effect of the evaluation of the system that the university launched
Read MoreAcouSort launches new project with Instrumentation Laboratory
RegulatorySince 2015, AcouSort has worked with Instrumentation Laboratory (IL) on the integration of its technology in IL’s clinical analysis system. The new project aims to investigate whether AcouSort’s technology can
Read MoreAcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future
AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification of patients’ own stem cells for further use in clinical applications
Read MoreAcouSort participates in a new important CAMP project
AcouSort will participate in yet another CAMP project. The goal is to develop a GMP-approved production of stem cells. Among other participants in the project are the Region Örebro län,
Read MoreInterim report Q2 2020
RegulatoryOn August 26, AcouSort released its interim report for the second quarter of 2020. The report can be found in Swedish and English here: AcouSort Interim report Q2 2020. For all
Read MoreAcouSort signs agreement with Korean life science company
AcouSort has signed a cooperation agreement with another Korean life science company. The agreement concerns the evaluation of the AcouTrap technology to develop a diagnostic test for the detection of
Read MoreAcouSort successfully completes product development assignment for Instrumentation Laboratory
AcouSort and the world-leading medical technology company Instrumentation Laboratory Inc. (IL) have an on-going collaboration. AcouSort has now successfully completed the second project in the collaboration agreement from 2018. –
Read MoreAcouSort launches a directed share issue valued SEK 11.7 million to complete development of the company’s first series of OEM-manufactured modules and the production line for these
RegulatoryAcouSort has today decided, for strategic reasons, to carry out a directed share issue totaling SEK 11.7 million to a consortium of existing shareholders and new targeted investors. Thus, the
Read MoreAcouSort receives ISO 13485 certification – an important step towards commercialization
RegulatoryDuring spring, AcouSort has worked on certifying the company’s quality management system. The auditing process has now been completed without deviations, which means that the company is ISO 13485 certified.
Read MoreAcouSort receives EUR 300 000 in Eurostars grant to develop stem cell therapy equipment
AcouSort AB (publ) (“AcouSort”) receives funding from Vinnova through Eurostars for the Blue4Therapy project. The aim of the project is to develop a system for the establishment of adipose tissue
Read More